APAC IPOs & Placements, Aequitas Research

Ethan Aw

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

ECM Weekly (8th Jan 2022) - Sinohytec, Beauty Farm, Sula, Kfin, Bionote, Meidong, CIFI, Jinxin Fert

ECM Weekly (15th Jan 2023) - 2022 Performance, 2023 Pipeline, Bilibili, HTHT, China Edu, CDP, Allied

ECM Weekly (20th Jan 23) - HK Brokers, Wuxi, IQIYI, Anycol, Adani, WM Mot, LG Ene, AIn, Oasis, Perta

Jinxin Fertility: Shenzhen and Yunnan Acquisitions

2022 High Conviction: Tail Winds for Jinxin Fertility

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Jinxin Fertility Group  / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/jinxin-fertility-group-ltd" target="_blank" data-smartkarma-citation="entities:28003:1" rel="noopener">Jinxin Fertility Co Ltd (1951 HK)</a> is looking to raise US$122m via a top-up placement. </li>
<li>Proceeds from the offering will be used to repay its outstanding convertible bond and general corporate purposes. </li>
<li>In this note, we will run the deal through our ECM framework and talk about the recent updates.</li>
</ul>



Jinxin Fertility Co Ltd (1951 HK) is looking to raise US$122m via a top-up placement. 
Proceeds from the offering will be used to repay its outstanding convertible bond and general corporate purposes. 
In this note, we will run the deal through our ECM framework and talk about the recent updates.


Jinxin Fertility Group Placement - Weak Track Record And Recent Deals Have Performed Poorly